Literature DB >> 8384753

Down-regulation of the surface expression of class I MHC antigens by human cytomegalovirus.

Y Yamashita1, K Shimokata, S Mizuno, H Yamaguchi, Y Nishiyama.   

Abstract

Class I major histocompatibility complex (MHC) antigens of higher eukaryotes play a crucial role in the recognition of human cytomegalovirus (HCMV)-infected cells by cytotoxic T lymphocytes. In the present study, we have demonstrated that HCMV infection resulted in a marked reduction in the surface expression of class I MHC antigens on human embryonic lung fibroblasts (HEL). Even when HCMV-infected HEL were cultured in the presence of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine (DHPG), the reduction was observed to the same extent, indicating that HCMV DNA synthesis was not required for this phenomenon. However, immunoprecipitation studies have shown that there was no significant reduction in the synthesis of either the heavy chain or the light chain of class I MHC antigens after HCMV infection. In addition, Western blotting studies have revealed that the total amount of the antigens was almost unaltered after HCMV infection. These results suggest that the reduction in the cell surface expression of class I MHC antigens is due to some defect occurring post-translationally, most likely at the level of the correct complex formation and/or the intracellular transport of class I MHC antigens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384753     DOI: 10.1006/viro.1993.1181

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells.

Authors:  B H Harcourt; A Sanchez; M K Offermann
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance.

Authors:  C Benz; H Hengel
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

3.  The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation.

Authors:  P J Lehner; J T Karttunen; G W Wilkinson; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

Review 4.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

5.  The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.

Authors:  M R Wills; A J Carmichael; K Mynard; X Jin; M P Weekes; B Plachter; J G Sissons
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 6.  Modulation of major histocompatibility complex antigen expression by viral infection.

Authors:  C R Rinaldo
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

7.  Rapid degradation of the heavy chain of class I major histocompatibility complex antigens in the endoplasmic reticulum of human cytomegalovirus-infected cells.

Authors:  Y Yamashita; K Shimokata; S Saga; S Mizuno; T Tsurumi; Y Nishiyama
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Down-regulation of major histocompatibility complex class I synthesis by murine cytomegalovirus early gene expression.

Authors:  A E Campbell; J S Slater
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Double fluorescence analysis of human cytomegalovirus (HCMV) infected human fibroblast cultures by flow cytometry: increase of class I MHC expression on uninfected cells and decrease on infected cells.

Authors:  M Steinmassl; K Hamprecht
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Regulation of major histocompatibility complex class II expression by Pasteurella haemolytica leukotoxin.

Authors:  H P Hughes; M Campos; L McDougall; T K Beskorwayne; A A Potter; L A Babiuk
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.